Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Work Schedule Tolerance | 56 | 2023 | 553 | 10.300 |
Why?
|
Melatonin | 42 | 2024 | 670 | 7.500 |
Why?
|
Nurses | 39 | 2023 | 2501 | 5.330 |
Why?
|
Circadian Rhythm | 46 | 2024 | 2593 | 4.880 |
Why?
|
Sleep | 31 | 2024 | 4820 | 2.260 |
Why?
|
Austria | 21 | 2024 | 209 | 2.020 |
Why?
|
Breast Neoplasms | 43 | 2023 | 21188 | 1.790 |
Why?
|
Occupational Diseases | 11 | 2023 | 1458 | 1.690 |
Why?
|
Photoperiod | 3 | 2023 | 141 | 1.430 |
Why?
|
Sleep Initiation and Maintenance Disorders | 8 | 2023 | 1106 | 1.400 |
Why?
|
Lighting | 8 | 2023 | 210 | 1.370 |
Why?
|
Light | 8 | 2015 | 1355 | 1.340 |
Why?
|
Depression | 13 | 2024 | 8231 | 1.280 |
Why?
|
Risk Factors | 115 | 2024 | 74976 | 1.220 |
Why?
|
Life Style | 16 | 2024 | 3931 | 1.120 |
Why?
|
Urinary Bladder Neoplasms | 6 | 2023 | 2251 | 1.100 |
Why?
|
Suicide | 5 | 2024 | 1606 | 1.100 |
Why?
|
Folic Acid | 6 | 2014 | 1338 | 1.050 |
Why?
|
Prospective Studies | 75 | 2024 | 54962 | 1.010 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 8 | 2015 | 416 | 1.010 |
Why?
|
Parkinson Disease | 14 | 2015 | 2895 | 1.000 |
Why?
|
Female | 202 | 2024 | 397515 | 1.000 |
Why?
|
Pineal Gland | 3 | 2023 | 158 | 0.970 |
Why?
|
Vitamin B 6 | 4 | 2014 | 237 | 0.950 |
Why?
|
Humans | 269 | 2024 | 768970 | 0.920 |
Why?
|
Pets | 1 | 2024 | 47 | 0.910 |
Why?
|
Colorectal Neoplasms | 20 | 2023 | 6982 | 0.900 |
Why?
|
Mothers | 6 | 2022 | 2209 | 0.890 |
Why?
|
Occupational Exposure | 10 | 2023 | 1807 | 0.880 |
Why?
|
Menopause | 5 | 2020 | 1656 | 0.880 |
Why?
|
Adult | 133 | 2024 | 223851 | 0.880 |
Why?
|
Chronobiology Disorders | 4 | 2019 | 73 | 0.880 |
Why?
|
Reproductive History | 2 | 2020 | 210 | 0.860 |
Why?
|
Veterinarians | 1 | 2023 | 13 | 0.860 |
Why?
|
Maternal Nutritional Physiological Phenomena | 2 | 2024 | 395 | 0.850 |
Why?
|
European Union | 1 | 2023 | 158 | 0.830 |
Why?
|
Middle Aged | 142 | 2024 | 223737 | 0.830 |
Why?
|
Seasons | 4 | 2023 | 1524 | 0.790 |
Why?
|
Premenopause | 7 | 2013 | 1039 | 0.780 |
Why?
|
Occupational Health | 7 | 2016 | 812 | 0.770 |
Why?
|
Proportional Hazards Models | 26 | 2022 | 12562 | 0.760 |
Why?
|
Trust | 2 | 2023 | 532 | 0.760 |
Why?
|
Insulin-Like Growth Factor I | 8 | 2015 | 1943 | 0.760 |
Why?
|
Diet | 10 | 2024 | 8088 | 0.740 |
Why?
|
Hormones | 3 | 2020 | 870 | 0.740 |
Why?
|
Rhinitis, Allergic, Seasonal | 2 | 2020 | 104 | 0.730 |
Why?
|
Hair Dyes | 1 | 2020 | 30 | 0.720 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2024 | 2542 | 0.720 |
Why?
|
Body Size | 3 | 2015 | 463 | 0.710 |
Why?
|
Physicians | 5 | 2024 | 4607 | 0.700 |
Why?
|
Pandemics | 8 | 2024 | 8749 | 0.700 |
Why?
|
Cardiovascular Diseases | 15 | 2024 | 15661 | 0.690 |
Why?
|
Odds Ratio | 26 | 2020 | 9684 | 0.680 |
Why?
|
Ownership | 1 | 2022 | 344 | 0.680 |
Why?
|
Time Factors | 32 | 2020 | 40261 | 0.680 |
Why?
|
Strigiformes | 1 | 2019 | 2 | 0.670 |
Why?
|
Passeriformes | 1 | 2019 | 3 | 0.670 |
Why?
|
Wakefulness | 4 | 2017 | 1284 | 0.670 |
Why?
|
Neoplasms | 22 | 2024 | 22389 | 0.650 |
Why?
|
Butyrates | 1 | 2019 | 167 | 0.640 |
Why?
|
Sleep Stages | 1 | 2023 | 706 | 0.630 |
Why?
|
Adult Children | 1 | 2019 | 104 | 0.620 |
Why?
|
Postmenopause | 8 | 2019 | 2519 | 0.620 |
Why?
|
Cohort Studies | 46 | 2024 | 41808 | 0.610 |
Why?
|
Anxiety | 3 | 2024 | 4672 | 0.610 |
Why?
|
Obesity | 15 | 2024 | 13091 | 0.610 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.600 |
Why?
|
Long Interspersed Nucleotide Elements | 5 | 2012 | 332 | 0.590 |
Why?
|
Vitamin B 12 | 3 | 2014 | 529 | 0.590 |
Why?
|
Efficiency | 1 | 2021 | 480 | 0.590 |
Why?
|
Overweight | 4 | 2024 | 2448 | 0.580 |
Why?
|
Dietary Sucrose | 2 | 2012 | 242 | 0.570 |
Why?
|
Smoking | 10 | 2023 | 9094 | 0.570 |
Why?
|
Sleep Disorders, Circadian Rhythm | 4 | 2021 | 197 | 0.560 |
Why?
|
Carcinoma, Basal Cell | 3 | 2020 | 565 | 0.550 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2016 | 31 | 0.550 |
Why?
|
Cognition | 9 | 2023 | 7081 | 0.550 |
Why?
|
Uncertainty | 2 | 2021 | 769 | 0.530 |
Why?
|
Case-Control Studies | 28 | 2020 | 22296 | 0.530 |
Why?
|
Insulin-Like Growth Factor II | 3 | 2014 | 271 | 0.520 |
Why?
|
Alcohol Drinking | 6 | 2018 | 4045 | 0.520 |
Why?
|
Vitamin B Complex | 2 | 2008 | 299 | 0.520 |
Why?
|
Hypertension | 9 | 2023 | 8617 | 0.520 |
Why?
|
Aged | 85 | 2024 | 171786 | 0.510 |
Why?
|
Colonic Neoplasms | 5 | 2011 | 2543 | 0.500 |
Why?
|
Body Mass Index | 27 | 2024 | 13055 | 0.500 |
Why?
|
Pregnancy | 16 | 2024 | 30265 | 0.490 |
Why?
|
Proton Pump Inhibitors | 2 | 2020 | 552 | 0.490 |
Why?
|
Risk | 16 | 2023 | 9621 | 0.490 |
Why?
|
Vitamin D | 4 | 2016 | 3311 | 0.490 |
Why?
|
Sweetening Agents | 2 | 2019 | 290 | 0.480 |
Why?
|
Methionine | 3 | 2014 | 573 | 0.480 |
Why?
|
Birth Weight | 2 | 2024 | 2121 | 0.470 |
Why?
|
Growth Hormone | 2 | 2007 | 573 | 0.470 |
Why?
|
Communicable Disease Control | 2 | 2020 | 857 | 0.470 |
Why?
|
Feeding Behavior | 4 | 2023 | 3205 | 0.460 |
Why?
|
Incidence | 30 | 2024 | 21547 | 0.450 |
Why?
|
Cross-Sectional Studies | 27 | 2024 | 26395 | 0.450 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2020 | 4064 | 0.450 |
Why?
|
Resilience, Psychological | 1 | 2021 | 807 | 0.440 |
Why?
|
United States | 41 | 2024 | 73186 | 0.430 |
Why?
|
Denmark | 11 | 2015 | 776 | 0.430 |
Why?
|
Stress, Psychological | 6 | 2019 | 4530 | 0.430 |
Why?
|
Male | 86 | 2024 | 365203 | 0.410 |
Why?
|
Skin Neoplasms | 3 | 2020 | 5864 | 0.410 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.410 |
Why?
|
Dermatitis, Atopic | 1 | 2020 | 737 | 0.410 |
Why?
|
Logistic Models | 17 | 2020 | 13318 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.410 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 8 | 2011 | 2276 | 0.400 |
Why?
|
Personnel Staffing and Scheduling | 3 | 2016 | 497 | 0.400 |
Why?
|
Age Factors | 17 | 2020 | 18435 | 0.400 |
Why?
|
Somatomedins | 3 | 2007 | 179 | 0.390 |
Why?
|
Adolescent Development | 1 | 2015 | 279 | 0.390 |
Why?
|
Disease | 1 | 2017 | 673 | 0.380 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 3 | 2007 | 126 | 0.380 |
Why?
|
Optical Devices | 1 | 2011 | 35 | 0.380 |
Why?
|
Research | 1 | 2020 | 1981 | 0.380 |
Why?
|
Disorders of Excessive Somnolence | 2 | 2022 | 279 | 0.370 |
Why?
|
Carbonated Beverages | 1 | 2012 | 210 | 0.370 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 790 | 0.370 |
Why?
|
Gout Suppressants | 1 | 2013 | 177 | 0.370 |
Why?
|
Hot Flashes | 1 | 2014 | 330 | 0.370 |
Why?
|
Cause of Death | 6 | 2024 | 3721 | 0.360 |
Why?
|
Influenza, Human | 1 | 2022 | 1542 | 0.360 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2024 | 12253 | 0.360 |
Why?
|
Ethanol | 2 | 2014 | 1331 | 0.350 |
Why?
|
Endometrial Neoplasms | 3 | 2008 | 1386 | 0.350 |
Why?
|
Cholecystectomy | 2 | 2003 | 409 | 0.340 |
Why?
|
Menstrual Cycle | 4 | 2019 | 546 | 0.340 |
Why?
|
CpG Islands | 3 | 2012 | 1210 | 0.340 |
Why?
|
Adenoma | 5 | 2017 | 2163 | 0.340 |
Why?
|
Energy Intake | 2 | 2014 | 2146 | 0.340 |
Why?
|
Aspartame | 2 | 2023 | 19 | 0.330 |
Why?
|
Multivariate Analysis | 13 | 2019 | 12095 | 0.320 |
Why?
|
Pancreatic Neoplasms | 6 | 2007 | 5443 | 0.310 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 1473 | 0.310 |
Why?
|
DNA Methylation | 8 | 2014 | 4432 | 0.310 |
Why?
|
Antihypertensive Agents | 4 | 2022 | 2027 | 0.310 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 3 | 2007 | 208 | 0.300 |
Why?
|
Diabetes Mellitus | 4 | 2023 | 5892 | 0.300 |
Why?
|
Physicians, Women | 2 | 2024 | 521 | 0.300 |
Why?
|
Risk Assessment | 25 | 2020 | 24333 | 0.300 |
Why?
|
Work | 3 | 2015 | 195 | 0.290 |
Why?
|
Young Adult | 18 | 2022 | 60131 | 0.290 |
Why?
|
Follow-Up Studies | 22 | 2024 | 39394 | 0.290 |
Why?
|
Occupations | 4 | 2024 | 516 | 0.290 |
Why?
|
Aging | 9 | 2021 | 8745 | 0.290 |
Why?
|
Neoplasms, Glandular and Epithelial | 3 | 2016 | 489 | 0.280 |
Why?
|
Epirubicin | 3 | 1995 | 81 | 0.280 |
Why?
|
Sex Factors | 11 | 2024 | 10633 | 0.280 |
Why?
|
Endometriosis | 2 | 2015 | 874 | 0.280 |
Why?
|
Cognition Disorders | 4 | 2019 | 3985 | 0.270 |
Why?
|
Ovarian Neoplasms | 8 | 2020 | 4919 | 0.270 |
Why?
|
Human Development | 1 | 2007 | 122 | 0.270 |
Why?
|
Homocysteine | 2 | 2022 | 637 | 0.270 |
Why?
|
Meat | 1 | 2009 | 588 | 0.260 |
Why?
|
Kidney Calculi | 2 | 2021 | 469 | 0.260 |
Why?
|
Affect | 1 | 2014 | 1500 | 0.260 |
Why?
|
Free Radical Scavengers | 1 | 2007 | 213 | 0.260 |
Why?
|
Asthma | 2 | 2020 | 6293 | 0.260 |
Why?
|
Wrist Injuries | 1 | 2008 | 215 | 0.260 |
Why?
|
Genes, ras | 1 | 2008 | 665 | 0.250 |
Why?
|
Gout | 1 | 2013 | 621 | 0.250 |
Why?
|
Longitudinal Studies | 9 | 2023 | 14794 | 0.250 |
Why?
|
Complementary Therapies | 1 | 2009 | 487 | 0.250 |
Why?
|
Melanoma | 2 | 2016 | 5709 | 0.250 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2008 | 399 | 0.240 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2012 | 1376 | 0.240 |
Why?
|
Nursing | 1 | 2004 | 35 | 0.240 |
Why?
|
Workplace | 1 | 2011 | 873 | 0.240 |
Why?
|
Reproduction | 2 | 2019 | 646 | 0.240 |
Why?
|
Gonadal Steroid Hormones | 2 | 2006 | 708 | 0.240 |
Why?
|
Health Personnel | 3 | 2023 | 3383 | 0.230 |
Why?
|
Aircraft | 1 | 2005 | 135 | 0.230 |
Why?
|
Europe | 4 | 2024 | 3441 | 0.230 |
Why?
|
Polymorphism, Genetic | 2 | 2006 | 4251 | 0.230 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1388 | 0.230 |
Why?
|
Leukemia | 1 | 2012 | 1520 | 0.230 |
Why?
|
Multiple Sclerosis | 1 | 2019 | 3250 | 0.230 |
Why?
|
Epigenesis, Genetic | 3 | 2014 | 3836 | 0.230 |
Why?
|
Cyclin D1 | 1 | 2006 | 453 | 0.230 |
Why?
|
Aspirin | 6 | 2011 | 3135 | 0.220 |
Why?
|
Antioxidants | 1 | 2012 | 1673 | 0.220 |
Why?
|
Aged, 80 and over | 28 | 2020 | 59739 | 0.220 |
Why?
|
Pregnancy Proteins | 1 | 2005 | 222 | 0.220 |
Why?
|
Eugenol | 1 | 2023 | 10 | 0.220 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2017 | 1143 | 0.220 |
Why?
|
Creatinine | 5 | 2020 | 1917 | 0.220 |
Why?
|
Drug Prescriptions | 1 | 2013 | 1673 | 0.220 |
Why?
|
Estrone | 1 | 2004 | 234 | 0.210 |
Why?
|
Sunlight | 2 | 2023 | 337 | 0.210 |
Why?
|
Attitude to Health | 2 | 2009 | 2025 | 0.210 |
Why?
|
Quality of Life | 4 | 2023 | 13510 | 0.210 |
Why?
|
Eczema | 2 | 2020 | 245 | 0.200 |
Why?
|
Delphi Technique | 2 | 2024 | 890 | 0.200 |
Why?
|
Estradiol | 4 | 2013 | 1952 | 0.200 |
Why?
|
Sex Distribution | 2 | 2024 | 2280 | 0.200 |
Why?
|
Phosphatidylcholines | 1 | 2024 | 406 | 0.200 |
Why?
|
Health Behavior | 3 | 2015 | 2649 | 0.200 |
Why?
|
Testosterone | 1 | 2013 | 2493 | 0.200 |
Why?
|
Choline | 1 | 2024 | 522 | 0.200 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2011 | 2059 | 0.200 |
Why?
|
Menstruation Disturbances | 2 | 2015 | 143 | 0.190 |
Why?
|
Snoring | 3 | 2022 | 211 | 0.190 |
Why?
|
Finland | 1 | 2023 | 609 | 0.190 |
Why?
|
Mortality | 6 | 2024 | 2914 | 0.190 |
Why?
|
Biological Clocks | 1 | 2024 | 321 | 0.190 |
Why?
|
Digestive System Neoplasms | 1 | 2021 | 82 | 0.190 |
Why?
|
Dentists | 1 | 2023 | 176 | 0.190 |
Why?
|
Object Attachment | 1 | 2024 | 331 | 0.190 |
Why?
|
Inflammation | 2 | 2019 | 10868 | 0.190 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 325 | 0.180 |
Why?
|
Dehydroepiandrosterone | 2 | 2017 | 259 | 0.180 |
Why?
|
Government | 1 | 2022 | 161 | 0.180 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 361 | 0.180 |
Why?
|
Adolescent | 13 | 2022 | 89244 | 0.180 |
Why?
|
Nutrition Assessment | 1 | 2024 | 740 | 0.180 |
Why?
|
Fractures, Bone | 2 | 2014 | 2063 | 0.180 |
Why?
|
Urban Health | 1 | 2023 | 535 | 0.180 |
Why?
|
Cholelithiasis | 1 | 2002 | 408 | 0.180 |
Why?
|
Pharmacists | 1 | 2023 | 261 | 0.180 |
Why?
|
Vitamin A | 1 | 2003 | 611 | 0.180 |
Why?
|
Waist-Hip Ratio | 2 | 2015 | 520 | 0.180 |
Why?
|
Mycotoxins | 1 | 2020 | 35 | 0.180 |
Why?
|
Olfaction Disorders | 1 | 2023 | 225 | 0.180 |
Why?
|
Leishmaniasis, Visceral | 1 | 2021 | 100 | 0.170 |
Why?
|
Caffeine | 2 | 2015 | 703 | 0.170 |
Why?
|
Hydrocortisone | 2 | 2019 | 1841 | 0.170 |
Why?
|
Congresses as Topic | 2 | 2021 | 812 | 0.170 |
Why?
|
Beverages | 1 | 2005 | 819 | 0.170 |
Why?
|
Infectious Disease Medicine | 1 | 2020 | 49 | 0.170 |
Why?
|
Respiratory Tract Diseases | 2 | 2024 | 744 | 0.170 |
Why?
|
Registries | 11 | 2022 | 8384 | 0.170 |
Why?
|
Knowledge | 1 | 2021 | 178 | 0.170 |
Why?
|
alpha-Amylases | 1 | 2019 | 39 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9442 | 0.160 |
Why?
|
Child | 11 | 2023 | 80960 | 0.160 |
Why?
|
Coronary Artery Disease | 2 | 2016 | 6569 | 0.160 |
Why?
|
Vaccination | 2 | 2022 | 3438 | 0.160 |
Why?
|
Prevalence | 10 | 2023 | 15879 | 0.160 |
Why?
|
Steroids | 1 | 2004 | 938 | 0.160 |
Why?
|
Dogs | 1 | 2024 | 3845 | 0.160 |
Why?
|
Adolescent Behavior | 1 | 2007 | 1188 | 0.160 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 252 | 0.160 |
Why?
|
Animals | 15 | 2024 | 169335 | 0.160 |
Why?
|
Intergenerational Relations | 1 | 2019 | 68 | 0.160 |
Why?
|
Nutritional Status | 1 | 2007 | 1627 | 0.150 |
Why?
|
Hypersensitivity | 1 | 2007 | 1173 | 0.150 |
Why?
|
Science | 1 | 2021 | 236 | 0.150 |
Why?
|
Social Responsibility | 1 | 2021 | 384 | 0.150 |
Why?
|
Hip Fractures | 2 | 2022 | 997 | 0.150 |
Why?
|
Alzheimer Disease | 4 | 2023 | 8760 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 369 | 0.150 |
Why?
|
Isoenzymes | 1 | 2003 | 1687 | 0.150 |
Why?
|
Health Surveys | 6 | 2019 | 4055 | 0.150 |
Why?
|
A Kinase Anchor Proteins | 1 | 2018 | 57 | 0.150 |
Why?
|
Arylalkylamine N-Acetyltransferase | 1 | 2017 | 13 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 529 | 0.140 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2008 | 2960 | 0.140 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2019 | 558 | 0.140 |
Why?
|
Students | 1 | 2007 | 1744 | 0.140 |
Why?
|
Carcinoma | 1 | 2008 | 2340 | 0.140 |
Why?
|
Cultural Diversity | 1 | 2021 | 373 | 0.140 |
Why?
|
Saliva | 2 | 2019 | 854 | 0.140 |
Why?
|
Lung Neoplasms | 5 | 2020 | 13594 | 0.140 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2018 | 199 | 0.140 |
Why?
|
Nerve Tissue Proteins | 3 | 2017 | 4413 | 0.140 |
Why?
|
Pre-Eclampsia | 2 | 2023 | 1255 | 0.140 |
Why?
|
Renal Replacement Therapy | 1 | 2019 | 282 | 0.140 |
Why?
|
Dietary Supplements | 2 | 2024 | 3443 | 0.140 |
Why?
|
Preconception Care | 1 | 2018 | 143 | 0.140 |
Why?
|
Urothelium | 1 | 2018 | 276 | 0.140 |
Why?
|
Health Policy | 2 | 2021 | 2700 | 0.130 |
Why?
|
Epidemiologic Studies | 1 | 2020 | 677 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 7 | 2018 | 18068 | 0.130 |
Why?
|
Walking | 1 | 2024 | 1201 | 0.130 |
Why?
|
Anti-Mullerian Hormone | 1 | 2019 | 420 | 0.130 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2021 | 16053 | 0.130 |
Why?
|
Population Surveillance | 3 | 2021 | 2597 | 0.130 |
Why?
|
Biological Specimen Banks | 2 | 2021 | 789 | 0.130 |
Why?
|
Parturition | 1 | 2020 | 456 | 0.130 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 148 | 0.130 |
Why?
|
Chronic Disease | 4 | 2023 | 9384 | 0.130 |
Why?
|
Mendelian Randomization Analysis | 1 | 2021 | 1040 | 0.130 |
Why?
|
Erythrocytes | 2 | 1995 | 2421 | 0.130 |
Why?
|
Quinine | 1 | 1995 | 51 | 0.120 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2021 | 1899 | 0.120 |
Why?
|
Pregnancy Trimester, Second | 1 | 2018 | 736 | 0.120 |
Why?
|
Estrogens | 1 | 2002 | 1536 | 0.120 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 4056 | 0.120 |
Why?
|
Blindness | 2 | 2009 | 587 | 0.120 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2016 | 306 | 0.120 |
Why?
|
Interviews as Topic | 2 | 2015 | 2744 | 0.120 |
Why?
|
Spinal Fractures | 1 | 2022 | 712 | 0.120 |
Why?
|
Environmental Exposure | 2 | 2022 | 4544 | 0.120 |
Why?
|
Lifting | 1 | 2015 | 56 | 0.120 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2016 | 218 | 0.120 |
Why?
|
Carcinogens, Environmental | 1 | 2015 | 70 | 0.120 |
Why?
|
Residence Characteristics | 2 | 2015 | 2121 | 0.120 |
Why?
|
Genotype | 6 | 2018 | 13048 | 0.120 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5196 | 0.120 |
Why?
|
Chronotherapy | 3 | 2022 | 11 | 0.120 |
Why?
|
Creatine | 1 | 2016 | 427 | 0.120 |
Why?
|
Women's Health | 3 | 2020 | 2081 | 0.120 |
Why?
|
Interprofessional Relations | 1 | 2020 | 997 | 0.120 |
Why?
|
Ovary | 1 | 2019 | 965 | 0.120 |
Why?
|
International Agencies | 1 | 2015 | 244 | 0.110 |
Why?
|
Drug Resistance, Multiple | 1 | 1995 | 255 | 0.110 |
Why?
|
Age of Onset | 2 | 2019 | 3346 | 0.110 |
Why?
|
Prostatic Neoplasms | 6 | 2017 | 11230 | 0.110 |
Why?
|
Interferon-alpha | 2 | 1995 | 910 | 0.110 |
Why?
|
Microsatellite Instability | 4 | 2012 | 726 | 0.110 |
Why?
|
Fertility | 2 | 2015 | 771 | 0.110 |
Why?
|
DNA, Neoplasm | 2 | 2009 | 1748 | 0.110 |
Why?
|
Linear Models | 5 | 2019 | 5891 | 0.110 |
Why?
|
Benchmarking | 1 | 2020 | 1059 | 0.110 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7861 | 0.110 |
Why?
|
Self Report | 4 | 2022 | 3773 | 0.110 |
Why?
|
Carcinoma, Papillary | 1 | 2018 | 793 | 0.110 |
Why?
|
Epidemiologic Methods | 3 | 2010 | 1328 | 0.110 |
Why?
|
Exercise | 3 | 2024 | 5954 | 0.110 |
Why?
|
Epidemiologic Research Design | 1 | 2016 | 368 | 0.110 |
Why?
|
Diet, Mediterranean | 1 | 2020 | 748 | 0.100 |
Why?
|
Weight Gain | 3 | 2024 | 2359 | 0.100 |
Why?
|
Schools | 1 | 2022 | 1498 | 0.100 |
Why?
|
Publications | 1 | 2015 | 195 | 0.100 |
Why?
|
Communicable Diseases | 1 | 2021 | 873 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1407 | 0.100 |
Why?
|
Public Health | 3 | 2021 | 2680 | 0.100 |
Why?
|
Body Weight | 2 | 2020 | 4628 | 0.100 |
Why?
|
Burnout, Professional | 1 | 2020 | 711 | 0.100 |
Why?
|
Hypercholesterolemia | 1 | 2019 | 1145 | 0.100 |
Why?
|
Calcium Channels, T-Type | 1 | 2011 | 28 | 0.100 |
Why?
|
Health Promotion | 1 | 2003 | 2210 | 0.090 |
Why?
|
Child, Preschool | 4 | 2024 | 42683 | 0.090 |
Why?
|
Nursing Staff, Hospital | 1 | 2015 | 350 | 0.090 |
Why?
|
Nursing Staff | 1 | 2012 | 113 | 0.090 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1995 | 682 | 0.090 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2011 | 58 | 0.090 |
Why?
|
Spouses | 1 | 2014 | 286 | 0.090 |
Why?
|
Polysomnography | 2 | 2016 | 1871 | 0.090 |
Why?
|
Comorbidity | 6 | 2020 | 10592 | 0.090 |
Why?
|
Early Detection of Cancer | 2 | 2023 | 3238 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3813 | 0.090 |
Why?
|
Calcium Channel Blockers | 2 | 2010 | 691 | 0.090 |
Why?
|
Maternal Exposure | 1 | 2018 | 1095 | 0.090 |
Why?
|
Actigraphy | 1 | 2015 | 527 | 0.090 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2666 | 0.090 |
Why?
|
Receptors, Retinoic Acid | 1 | 2011 | 229 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 178 | 0.090 |
Why?
|
Hair Color | 1 | 2011 | 131 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 755 | 0.090 |
Why?
|
Dihydropyridines | 1 | 2010 | 67 | 0.090 |
Why?
|
Epidemiology | 1 | 2013 | 278 | 0.090 |
Why?
|
Family Health | 1 | 2015 | 1255 | 0.090 |
Why?
|
Amlodipine | 1 | 2010 | 84 | 0.090 |
Why?
|
Double-Blind Method | 3 | 2014 | 12467 | 0.080 |
Why?
|
Pathology, Molecular | 1 | 2013 | 329 | 0.080 |
Why?
|
Renal Dialysis | 1 | 2019 | 1789 | 0.080 |
Why?
|
Medical Records | 1 | 2015 | 1411 | 0.080 |
Why?
|
Disease Progression | 4 | 2022 | 13674 | 0.080 |
Why?
|
Radioimmunoassay | 1 | 2010 | 862 | 0.080 |
Why?
|
Infertility, Female | 1 | 2015 | 764 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2528 | 0.080 |
Why?
|
Workload | 1 | 2015 | 852 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2022 | 14752 | 0.080 |
Why?
|
Progesterone | 1 | 2013 | 752 | 0.080 |
Why?
|
Vitamin B 6 Deficiency | 1 | 2008 | 18 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6086 | 0.080 |
Why?
|
Aromatase | 1 | 2008 | 147 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2011 | 507 | 0.080 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2974 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2018 | 6030 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 710 | 0.070 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1761 | 0.070 |
Why?
|
Blood Cells | 1 | 2010 | 309 | 0.070 |
Why?
|
Research Design | 4 | 2011 | 6214 | 0.070 |
Why?
|
Climacteric | 1 | 2007 | 57 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2020 | 20245 | 0.070 |
Why?
|
Folic Acid Deficiency | 1 | 2008 | 117 | 0.070 |
Why?
|
Colon | 2 | 2019 | 1803 | 0.070 |
Why?
|
Educational Status | 1 | 2015 | 2515 | 0.070 |
Why?
|
Caregivers | 2 | 2014 | 2308 | 0.070 |
Why?
|
Tryptophan | 1 | 2009 | 482 | 0.070 |
Why?
|
Sex Characteristics | 2 | 2020 | 2649 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2017 | 15471 | 0.070 |
Why?
|
Genome-Wide Association Study | 3 | 2021 | 12801 | 0.070 |
Why?
|
Physical Fitness | 2 | 2016 | 744 | 0.070 |
Why?
|
Electroencephalography | 1 | 2023 | 6317 | 0.070 |
Why?
|
Los Angeles | 1 | 2007 | 245 | 0.070 |
Why?
|
Epigenomics | 1 | 2013 | 961 | 0.070 |
Why?
|
Uric Acid | 1 | 2013 | 806 | 0.070 |
Why?
|
Education | 1 | 2009 | 533 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2493 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6856 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2297 | 0.070 |
Why?
|
Menarche | 1 | 2009 | 538 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2913 | 0.070 |
Why?
|
Chromatography, Liquid | 2 | 2020 | 997 | 0.060 |
Why?
|
Health Status | 1 | 2019 | 4095 | 0.060 |
Why?
|
Administration, Oral | 2 | 2012 | 4040 | 0.060 |
Why?
|
Time | 1 | 2007 | 552 | 0.060 |
Why?
|
Genes, p53 | 1 | 2008 | 716 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 1 | 2014 | 1568 | 0.060 |
Why?
|
Vitamins | 1 | 2014 | 1638 | 0.060 |
Why?
|
Cerebral Infarction | 1 | 2010 | 975 | 0.060 |
Why?
|
Dementia | 1 | 2020 | 2741 | 0.060 |
Why?
|
Social Support | 2 | 2006 | 2193 | 0.060 |
Why?
|
Receptors, Estrogen | 1 | 2013 | 2252 | 0.060 |
Why?
|
Life Change Events | 1 | 2010 | 961 | 0.060 |
Why?
|
Telomere | 1 | 2011 | 943 | 0.060 |
Why?
|
Alleles | 2 | 2015 | 6901 | 0.060 |
Why?
|
Coronary Disease | 1 | 2019 | 5919 | 0.060 |
Why?
|
Androstenols | 1 | 2004 | 25 | 0.060 |
Why?
|
Estrogen Receptor alpha | 1 | 2008 | 581 | 0.060 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 811 | 0.060 |
Why?
|
Sexual Harassment | 1 | 2005 | 82 | 0.060 |
Why?
|
Psoriasis | 1 | 2012 | 926 | 0.060 |
Why?
|
Myocardial Infarction | 2 | 2016 | 11521 | 0.060 |
Why?
|
Osteoporosis | 1 | 2014 | 1606 | 0.060 |
Why?
|
Androstenedione | 1 | 2004 | 132 | 0.060 |
Why?
|
Confidence Intervals | 2 | 2011 | 2932 | 0.060 |
Why?
|
Darkness | 1 | 2004 | 160 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2023 | 81903 | 0.060 |
Why?
|
Publication Bias | 1 | 2004 | 159 | 0.060 |
Why?
|
Amitriptyline | 1 | 2004 | 112 | 0.060 |
Why?
|
Ulnar Nerve | 1 | 2004 | 104 | 0.060 |
Why?
|
Serotonin | 1 | 2008 | 1043 | 0.060 |
Why?
|
Acetaminophen | 1 | 2008 | 556 | 0.060 |
Why?
|
Carcinogenicity Tests | 1 | 2023 | 39 | 0.060 |
Why?
|
Iceland | 2 | 2014 | 183 | 0.050 |
Why?
|
Cattle | 1 | 2009 | 3819 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2020 | 4300 | 0.050 |
Why?
|
Infant | 3 | 2022 | 36556 | 0.050 |
Why?
|
Biological Availability | 1 | 2004 | 392 | 0.050 |
Why?
|
Organoplatinum Compounds | 1 | 2005 | 408 | 0.050 |
Why?
|
Respiratory Sounds | 1 | 2007 | 702 | 0.050 |
Why?
|
Genetic Association Studies | 3 | 2018 | 2748 | 0.050 |
Why?
|
Survivors | 1 | 2014 | 2383 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2019 | 11116 | 0.050 |
Why?
|
Nutrition Surveys | 2 | 2021 | 1738 | 0.050 |
Why?
|
Social Isolation | 1 | 2006 | 366 | 0.050 |
Why?
|
Nucleoproteins | 1 | 2023 | 110 | 0.050 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2003 | 767 | 0.050 |
Why?
|
Xenobiotics | 1 | 2022 | 71 | 0.050 |
Why?
|
Survival Analysis | 4 | 2012 | 10115 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2019 | 65480 | 0.050 |
Why?
|
Morbidity | 1 | 2007 | 1757 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2020 | 26428 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2009 | 2437 | 0.050 |
Why?
|
Skin Temperature | 1 | 2022 | 96 | 0.050 |
Why?
|
Algorithms | 1 | 2023 | 14201 | 0.050 |
Why?
|
Secretory Rate | 1 | 2001 | 82 | 0.050 |
Why?
|
Prolactin | 1 | 2004 | 627 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2015 | 4939 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1926 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 318 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2008 | 1209 | 0.050 |
Why?
|
Neuropsychological Tests | 3 | 2023 | 7148 | 0.050 |
Why?
|
Blood Pressure | 3 | 2022 | 8544 | 0.050 |
Why?
|
Sequence Analysis, DNA | 2 | 2010 | 4785 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2011 | 1902 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2023 | 405 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2008 | 2848 | 0.050 |
Why?
|
Cross-Cultural Comparison | 1 | 2004 | 638 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2023 | 3215 | 0.050 |
Why?
|
Insulin Resistance | 2 | 2013 | 3982 | 0.050 |
Why?
|
Prejudice | 1 | 2005 | 574 | 0.050 |
Why?
|
Smell | 1 | 2023 | 261 | 0.050 |
Why?
|
Visual Perception | 1 | 2009 | 1407 | 0.040 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2003 | 319 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2911 | 0.040 |
Why?
|
France | 1 | 2022 | 497 | 0.040 |
Why?
|
Body Temperature Regulation | 1 | 2022 | 292 | 0.040 |
Why?
|
Australia | 1 | 2024 | 1265 | 0.040 |
Why?
|
Cyclooxygenase 2 | 1 | 2003 | 597 | 0.040 |
Why?
|
Lipid Metabolism | 1 | 2008 | 1904 | 0.040 |
Why?
|
Mass Vaccination | 1 | 2021 | 111 | 0.040 |
Why?
|
Genetic Variation | 1 | 2015 | 6611 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3709 | 0.040 |
Why?
|
Italy | 1 | 2022 | 856 | 0.040 |
Why?
|
Cell Division | 2 | 2004 | 4478 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2011 | 3450 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3810 | 0.040 |
Why?
|
Signal Transduction | 3 | 2019 | 23653 | 0.040 |
Why?
|
Specimen Handling | 1 | 2004 | 708 | 0.040 |
Why?
|
Stroke | 2 | 2014 | 9756 | 0.040 |
Why?
|
Circadian Clocks | 1 | 2021 | 168 | 0.040 |
Why?
|
Thyroid Hormones | 1 | 2022 | 407 | 0.040 |
Why?
|
Body Temperature | 1 | 2022 | 781 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2011 | 3608 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2023 | 917 | 0.040 |
Why?
|
Sleep Deprivation | 1 | 2006 | 848 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 9213 | 0.040 |
Why?
|
Food Contamination | 1 | 2020 | 193 | 0.040 |
Why?
|
Colonoscopy | 2 | 2023 | 1410 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2010 | 3044 | 0.040 |
Why?
|
Ferritins | 1 | 2021 | 600 | 0.040 |
Why?
|
Mood Disorders | 1 | 2005 | 1129 | 0.040 |
Why?
|
Universities | 1 | 2003 | 1005 | 0.040 |
Why?
|
Down-Regulation | 2 | 2016 | 2942 | 0.040 |
Why?
|
Drug Utilization | 1 | 2004 | 1191 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 473 | 0.040 |
Why?
|
Software Design | 1 | 2017 | 173 | 0.040 |
Why?
|
Zinc | 1 | 2021 | 677 | 0.040 |
Why?
|
Nerve Block | 1 | 2004 | 716 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2258 | 0.040 |
Why?
|
Glomerulonephritis | 1 | 2019 | 333 | 0.040 |
Why?
|
Brazil | 1 | 2021 | 1250 | 0.030 |
Why?
|
Fetal Development | 1 | 2022 | 777 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2009 | 3492 | 0.030 |
Why?
|
Semantics | 1 | 2020 | 618 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5804 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2001 | 1737 | 0.030 |
Why?
|
Fibrinogen | 1 | 2019 | 892 | 0.030 |
Why?
|
BCG Vaccine | 1 | 2019 | 383 | 0.030 |
Why?
|
Independent Living | 1 | 2020 | 584 | 0.030 |
Why?
|
Genomic Instability | 2 | 2010 | 715 | 0.030 |
Why?
|
Metabolome | 1 | 2023 | 1009 | 0.030 |
Why?
|
Drug Approval | 1 | 2003 | 821 | 0.030 |
Why?
|
Temperature | 1 | 2022 | 2235 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2005 | 2487 | 0.030 |
Why?
|
Information Systems | 1 | 2017 | 400 | 0.030 |
Why?
|
Data Collection | 1 | 2004 | 3324 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3253 | 0.030 |
Why?
|
Academies and Institutes | 1 | 2017 | 326 | 0.030 |
Why?
|
Epidemics | 1 | 2021 | 517 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 1995 | 363 | 0.030 |
Why?
|
Rectum | 1 | 2019 | 900 | 0.030 |
Why?
|
Environment | 1 | 2021 | 1122 | 0.030 |
Why?
|
Models, Biological | 3 | 2021 | 9499 | 0.030 |
Why?
|
Verapamil | 1 | 1995 | 242 | 0.030 |
Why?
|
Regression Analysis | 3 | 2013 | 6346 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1436 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1542 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2017 | 555 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1197 | 0.030 |
Why?
|
Half-Life | 1 | 1995 | 651 | 0.030 |
Why?
|
Adiposity | 1 | 2024 | 1895 | 0.030 |
Why?
|
Drug Interactions | 2 | 1995 | 1418 | 0.030 |
Why?
|
Urban Population | 1 | 2021 | 2046 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2019 | 1820 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2017 | 702 | 0.030 |
Why?
|
Prescription Drugs | 2 | 2010 | 635 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2005 | 3723 | 0.030 |
Why?
|
Pneumonia | 1 | 2024 | 2164 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2023 | 2784 | 0.020 |
Why?
|
Age Distribution | 2 | 2010 | 2875 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1469 | 0.020 |
Why?
|
Prognosis | 5 | 2011 | 30046 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2228 | 0.020 |
Why?
|
Triglycerides | 1 | 2019 | 2464 | 0.020 |
Why?
|
Breast Feeding | 1 | 2020 | 1364 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 937 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2021 | 3232 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2268 | 0.020 |
Why?
|
Climate Change | 1 | 2017 | 509 | 0.020 |
Why?
|
Lip Neoplasms | 1 | 2010 | 36 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3214 | 0.020 |
Why?
|
Biological Transport | 1 | 2015 | 2085 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4568 | 0.020 |
Why?
|
Cholesterol | 1 | 2019 | 2913 | 0.020 |
Why?
|
Phenotype | 1 | 2008 | 16731 | 0.020 |
Why?
|
Rural Population | 1 | 2021 | 2325 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2019 | 2403 | 0.020 |
Why?
|
Fluorouracil | 1 | 1995 | 1655 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2133 | 0.020 |
Why?
|
Sulfites | 1 | 2010 | 83 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2005 | 11886 | 0.020 |
Why?
|
Survival Rate | 3 | 2012 | 12873 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3626 | 0.020 |
Why?
|
Community Health Planning | 1 | 2010 | 164 | 0.020 |
Why?
|
Mass Screening | 1 | 2005 | 5457 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2007 | 10765 | 0.020 |
Why?
|
Mutation | 2 | 2011 | 30266 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3335 | 0.020 |
Why?
|
Medical History Taking | 1 | 2012 | 779 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2005 | 4423 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 1995 | 2108 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 1995 | 6512 | 0.020 |
Why?
|
Lipids | 1 | 2019 | 3345 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8748 | 0.020 |
Why?
|
Disease Susceptibility | 2 | 2005 | 1794 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2019 | 3859 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2007 | 4862 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3908 | 0.020 |
Why?
|
Chronobiology Phenomena | 1 | 2006 | 29 | 0.020 |
Why?
|
Sample Size | 1 | 2009 | 848 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 1645 | 0.020 |
Why?
|
Causality | 1 | 2012 | 1256 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2009 | 994 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2003 | 7885 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2006 | 315 | 0.020 |
Why?
|
Kidney | 1 | 2020 | 7058 | 0.020 |
Why?
|
Receptors, Somatomedin | 1 | 2004 | 57 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2011 | 1313 | 0.010 |
Why?
|
Community Networks | 1 | 2006 | 202 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11262 | 0.010 |
Why?
|
Etoposide | 1 | 2005 | 639 | 0.010 |
Why?
|
ras Proteins | 1 | 2008 | 1058 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2010 | 1541 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2010 | 1758 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4592 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2016 | 3116 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3438 | 0.010 |
Why?
|
Erythema | 1 | 2004 | 261 | 0.010 |
Why?
|
Protein Binding | 1 | 1995 | 9344 | 0.010 |
Why?
|
ROC Curve | 1 | 2010 | 3629 | 0.010 |
Why?
|
Somatostatin | 1 | 2004 | 458 | 0.010 |
Why?
|
Outpatients | 1 | 2010 | 1603 | 0.010 |
Why?
|
Social Class | 1 | 2010 | 2009 | 0.010 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2005 | 892 | 0.010 |
Why?
|
Coffee | 1 | 2006 | 594 | 0.010 |
Why?
|
Bupivacaine | 1 | 2004 | 414 | 0.010 |
Why?
|
Autoantibodies | 1 | 2009 | 2120 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 1769 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8664 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3629 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2006 | 2360 | 0.010 |
Why?
|
Biomedical Research | 1 | 2015 | 3463 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2005 | 8055 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2714 | 0.010 |
Why?
|
Longevity | 1 | 2004 | 1077 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2008 | 4528 | 0.010 |
Why?
|
Databases, Factual | 1 | 2010 | 8094 | 0.010 |
Why?
|
Homeostasis | 1 | 2004 | 3347 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2004 | 2905 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2231 | 0.010 |
Why?
|
Brain | 1 | 2016 | 27453 | 0.010 |
Why?
|
Pain | 1 | 2004 | 5100 | 0.000 |
Why?
|
Drug Resistance | 1 | 1995 | 1599 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36854 | 0.000 |
Why?
|
Apoptosis | 1 | 2004 | 9527 | 0.000 |
Why?
|
Mice | 1 | 2004 | 82072 | 0.000 |
Why?
|